Yep, I forgot about the podiatrist talk, but at that time they were anticipating the Diabetic Foot Ulcer Treatment trial would be completed relatively quickly. I don't know whether it has resumed, but the delay might have stalled any plans in that direction. But if or when it happens, that might well be a catalyst to a re-rating and another growth arm.
PNV - Chart, page-17552
-
- There are more pages in this discussion • 1,863 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.62 |
Change
0.100(3.97%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.66 | $2.58 | $2.252M | 860.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 187 | $2.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 22621 | 5 |
View Market Depth
| Last trade - 15.59pm 16/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |